Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/43339
Conference/Presentation Title: The expanding phenotypic spectrum of verheij syndrome.
Authors: Fennell A.P. ;Kumble S.;McKeown C.;Poke G.;Stark Z.;Stutterd C.A.;Tan T.Y.;Yeung A.;Wilkins E.J.;Hunter M.F. 
Institution: (Fennell, Hunter) Monash Genetics, Monash Health, Melbourne, Australia
(Fennell, Hunter) Department of Paediatrics, Monash University, Melbourne, Australia
(Kumble, Stark, Stutterd, Tan, Yeung, Wilkins) Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Melbourne, Australia
(McKeown, Poke) Genetic Health Service New Zealand, Wellington Hospital, Wellington, New Zealand
(Stark, Tan, Yeung) Department of Paediatrics, University of Melbourne, Melbourne, Australia
Presentation/Conference Date: 9-Jun-2021
Copyright year: 2021
Publisher: Cambridge University Press
Conference location: Netherlands
Publication information: Twin Research and Human Genetics. Conference: Human Genetics Society of Australasia Conference. Virtual. 24 (1) (pp 65), 2021. Date of Publication: February 2021.
Journal: Twin Research and Human Genetics
Abstract: Verheij syndrome is a rare craniofacial spliceosomopathy presenting with craniofacial dysmorphism, multiple congenital anomalies and variable neurodevelopmental delay. It is caused by SNVs in PUF60 or interstitial deletions of the chromosome 8q24.3 region. PUF60 encodes a splicing factor which forms part of the spliceosome. To date, 27 patients with Verheij syndrome due to disease-causing PUF60 SNVs have been detailed substantively in peer-reviewed publications. Although the depth of their phenotyping has varied greatly, they exhibit marked phenotypic heterogeneity. We report five additional unrelated patients, including the first described patients of Khmer and Indian ethnicities and the eldest patient to date, with five heterozygous PUF60 variants identified through exome sequencing, four previously unreported. These included three frameshift (p.(Pro385Leufs*12), p.(Gly268Alafs*18) and p.(Met287Ilefs*5)), one missense (p.(Arg146Cys)) and one inframe deletion variant (p.(Ala150-Phe152del)). All patients underwent deep phenotyping identifying variable dysmorphism, growth delay, neurodevelopmental delay, and multiple congenital anomalies, including several unique features. Our adult patient is the only individual reported not to have had either neurodevelopmental delay or intellectual disability. In combining these detailed phenotypic data with the previously reported patients we further refine the known frequencies of features associated with Verheij syndrome. These include neurodevelopmental delay/Intellectual disability (97%), short stature (60%), limb anomalies (66%), axial skeletal anomalies (57%), cardiac anomalies (61%), brain malformation (57%), hearing loss (48%), colobomata (32%) and other ocular anomalies (61%). This case series, incorporating two patients from previously unreported ethnic backgrounds, further delineates the mutational spectrum and unpredictable pleiotropy of PUF60 pathogenic variants.
DOI: http://dx.doi.org/10.1017/thg.2021.9
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/43339
Type: Conference Abstract
Subjects: body height
brain malformation
coloboma
congenital heart malformation
ethnicity
frameshift mutation
gene deletion
hearing impairment
heterozygosity
intellectual impairment
limb malformation
missense mutation
multiple malformation syndrome
phenotype
pleiotropy
single nucleotide polymorphism
skeleton malformation
whole exome sequencing
Appears in Collections:Conferences

Show full item record

Page view(s)

54
checked on Apr 24, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.